← FDA Drug Approvals (Drugs@FDA)
MIDOSTAURIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2024-05-10
Drug application
- FDA Application #
ANDA216015- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MIDOSTAURIN
- Generic name
- Midostaurin
- Active ingredients
- MIDOSTAURIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- LUPIN
- First approval
- 2024-05-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown